1. A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease. (11th June 2022) Authors: Pratta, Michael; Paczesny, Sophie; Socie, Gerard; Barkey, Natalie; Liu, Hao; Owens, Sherry; Arbushites, Michael C.; Schroeder, Mark A.; Howell, Michael D. Journal: British journal of haematology Issue: Volume 198:Number 4(2022) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML. Issue 8 (28th April 2014) Authors: Welch, John S.; Niu, Haixia; Uy, Geoffrey L.; Westervelt, Peter; Abboud, Camille N.; Vij, Ravi; Stockerl‐Goldstein, Keith E.; Jacoby, Meagan; Pusic, Iskra; Schroeder, Mark A.; Dipersio, John F.; Cashen, Amanda F. Journal: American journal of hematology Issue: Volume 89:Issue 8(2014:Aug.) Page Start: E103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes. Issue 6 (12th May 2021) Authors: Huselton, Eric; Rettig, Michael P.; Fletcher, Theresa; Ritchey, Julie; Gehrs, Leah; McFarland, Kyle; Christ, Stephanie; Eades, William C.; Trinkaus, Kathryn; Romee, Rizwan; Kulkarni, Shashikant; Ghobadi, Armin; Abboud, Camille; Cashen, Amanda F.; Stockerl-Goldstein, Keith; Uy, Geoffrey L.; Vij, R... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 6(2021) Page Start: 1441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Issue 2 (28th January 2023) Authors: Assouline, Sarit; Michaelis, Laura C.; Othus, Megan; Hay, Annette E.; Walter, Roland B.; Jacoby, Meagan A.; Schroeder, Mark A.; Uy, Geoffrey L.; Law, Lisa Y.; Cheema, Faisal; Sweet, Kendra L.; Asch, Adam S.; Liu, Jijun (Jane); Moseley, Anna B.; Maher, Tracy; Kingsbury, Laura L.; Fang, Min; Radich... Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma. Issue 12 (15th October 2021) Authors: Liu, Lawrence; Fiala, Mark; Gao, Feng; King, Justin; Goldsmith, Scott; Wildes, Tanya M.; Stockerl-Goldstein, Keith; Vij, Ravi; Schroeder, Mark A. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 12(2021) Page Start: 3043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass study. (April 2023) Authors: Slade, Michael; Fiala, Mark; Kelley, Sarah; Crees, Zachary D.; Schroeder, Mark A.; Stockerl-Goldstein, Keith; Vij, Ravi Journal: Leukemia research Issue: Volume 127(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of Glioblastoma. Issue 21 (2nd August 2017) Authors: Pedron, Sara; Hanselman, Jacob S.; Schroeder, Mark A.; Sarkaria, Jann N.; Harley, Brendan A. C. Journal: Advanced healthcare materials Issue: Volume 6:Issue 21(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results. Issue 11 (9th September 2018) Authors: Cortes, Jorge E.; Douglas Smith, B.; Wang, Eunice S.; Merchant, Akil; Oehler, Vivian G.; Arellano, Martha; DeAngelo, Daniel J.; Pollyea, Daniel A.; Sekeres, Mikkael A.; Robak, Tadeusz; Ma, Weidong Wendy; Zeremski, Mirjana; Naveed Shaik, M.; Douglas Laird, A.; O'Connell, Ashleigh; Chan, Geoffrey; ... Journal: American journal of hematology Issue: Volume 93:Issue 11(2018:Nov.) Page Start: 1301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia. (2021) Authors: Barnell, Erica K.; Newcomer, Kenneth F.; Skidmore, Zachary L.; Krysiak, Kilannin; Anderson, Sydney R.; Wartman, Lukas D.; Oh, Stephen T.; Welch, John S.; Stockerl-Goldstein, Keith E.; Vij, Ravi; Cashen, Amanda F.; Pusic, Iskra; Westervelt, Peter; Abboud, Camille N.; Ghobadi, Armin; Uy, Geoffrey L... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of a 40‐Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia. (December 2021) Authors: Barnell, Erica K.; Newcomer, Kenneth F.; Skidmore, Zachary L.; Krysiak, Kilannin; Anderson, Sydney R.; Wartman, Lukas D.; Oh, Stephen T.; Welch, John S.; Stockerl‐Goldstein, Keith E.; Vij, Ravi; Cashen, Amanda F.; Pusic, Iskra; Westervelt, Peter; Abboud, Camille N.; Ghobadi, Armin; Uy, Geoffrey L... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗